Skip Content
Page Banner Image

Observational Natural History Study

Back to map

This 15-month observational study aims to further understand the role of mHTT in disease progression. There is no drug treatment in this study, as the goal is to understand the natural progression of HD.

This study will include up to 100 participants globally with early manifest (Stage I and II) HD at up to 17 sites in Canada, Germany, the UK and the US. This study is expected to start enrollment soon.

These sites are not fully activated nor recruiting yet, but hope to complete the final steps as quickly as possible.

Study Type   

Canadian Locations


Location: Centre for Movement Disorders, Toronto at 1 Valleybrook Drive, Suite 400, Toronto, ON M3B 2S7
Coordinator: Susan Whyte
Phone: 416-847-7084 ext. 285
Status: Not yet recruiting

British Columbia

Location: Centre for HD, UBC Hospital, Vancouver
Coordinator: Emma Peachey
Phone: 604-822-5898
Status: Not yet recruiting

Verified November 7, 2018

We support those facing huntington disease
 Latest Blog


Let Us Know How We Can Help
Enter your name, email address and question(s) below for assistance.



Stay in Touch!
Enter your email address below to receive occasional updates.

Newsletter Sign-up